Skip to main content

Business Model

Moberg Pharma’s business model includes direct sales and sales through distributors and partners. Product development is based on innovative drug delivery and proven compounds, reducing time to market, development costs and risk compared with conventional drug development. Phase II trials for our projects are quickly initiated to evaluate the product in a limited number of patients. The selection of regulatory route is important – Moberg Pharma has experience with products that can be registered as pharmaceuticals, medical devices or cosmetics.

The business and marketing team at Moberg Pharma has solid experience in global product commercialization. The organization is supplemented with external expertise and capacity, in areas including clinical development, production and commercialization.